Stockscreener 앱 받기
17.89
1.92%
-0.35
시간 외 거래:
18.25
0.36
+2.01%
전일 마감가:
$18.24
열려 있는:
$18.12
하루 거래량:
1.03M
Relative Volume:
1.76
시가총액:
$1.30B
수익:
$188.48M
순이익/손실:
$-143.14M
주가수익비율:
31.95
EPS:
0.56
순현금흐름:
$-158.83M
1주 성능:
-4.54%
1개월 성능:
+2.17%
6개월 성능:
-24.45%
1년 성능:
-36.87%
1일 변동 폭
$17.73
$18.26
1주일 범위
$17.28
$18.92
52주 변동 폭
$16.67
$38.00
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Schrödinger (SDGR) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Schrödinger to Present at Jefferies London Healthcare Conference - BioSpace
(SDGR) Long Term Investment Analysis - Stock Traders Daily
How to Profit From an AI-Driven Biotech That Has Lost Half Its Value in 2024 - RealMoney
Schrödinger, Inc. (NASDAQ:SDGR) Shares Acquired by Stephens Investment Management Group LLC - MarketBeat
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Trading (SDGR) With Integrated Risk Controls - Stock Traders Daily
Stanley Laman Group Ltd. Sells 33,556 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium - Business Wire
Schrödinger (NASDAQ:SDGR) Stock Price Up 6.2%Time to Buy? - MarketBeat
Schrodinger (SDGR) Shares Surge Following Strong Buy Ratings - GuruFocus.com
Schrodinger Inc (SDGR) Shares Up 3.01% on Oct 22 - GuruFocus.com
Schrödinger’s Akinsanya On Low-Risk Pipeline Growth And Platform Evolution - Citeline
Schrödinger, Inc. Continues To Be A Complicated Story (NASDAQ:SDGR) - Seeking Alpha
Schrödinger (NASDAQ:SDGR) Price Target Cut to $25.00 - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Schrodinger's Path Forward: AI, Cash Burn, And Clinical Uncertainty (NASDAQ:SDGR) - Seeking Alpha
Schrodinger's chief medical officer sells $27,225 in stock - Investing.com India
Schrodinger's chief medical officer sells $27,225 in stock By Investing.com - Investing.com Australia
Schrödinger, Inc. (NASDAQ:SDGR) Insider Sells $27,221.18 in Stock - MarketBeat
How to Take Advantage of moves in (SDGR) - Stock Traders Daily
Schrodinger Inc (SDGR) Stock Price Up 3.52% on Oct 11 - GuruFocus.com
Schrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR Symposium - Business Wire
Millennium Management LLC Buys 471,399 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger (NASDAQ:SDGR) Hits New 52-Week LowHere's Why - MarketBeat
Dimensional Fund Advisors LP Sells 107,872 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Algert Global LLC Has $1.69 Million Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Schrodinger stock hits 52-week low at $18.02 amid market challenges By Investing.com - Investing.com South Africa
Schrodinger stock hits 52-week low at $18.02 amid market challenges - Investing.com India
Schrödinger (NASDAQ:SDGR) Sets New 12-Month Low at $17.99 - MarketBeat
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues - Simply Wall St
Schrodinger discovers EGFR mutant inhibitors - BioWorld Online
Goldman Sachs holds neutral on Schrodinger stock By Investing.com - Investing.com Canada
Goldman Sachs holds neutral on Schrodinger stock - Investing.com
(SDGR) Trading Advice - Stock Traders Daily
Rubric Capital Management LP Buys 2,131,724 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrodinger Inc (SDGR) Shares Gap Down to $20.02 on Sep 20 - GuruFocus.com
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm - The Malaysian Reserve
Schroders Capital Buys Back and Cancels Shares - TipRanks
Schwab 5-10 Year Corporate Bond ETF (NYSEARCA:SCHI) Hits New 12-Month High at $46.61 - Defense World
Commonwealth Equity Services LLC Increases Position in Schwab 5-10 Year Corporate Bond ETF (NYSEARCA:SCHI) - Defense World
Noteworthy Wednesday Option Activity: DUOL, ALGM, SPHR - Nasdaq
Stryker Stock Declines Despite Completion Of Care.ai Acquisition - Barchart
Schroder Income Growth (LON:SCF) Sets New 1-Year High at $305.00 - Defense World
Transaction in Own Shares - ShareCast
Schrödinger, Inc. (SDGR): A Bull Case Theory - Insider Monkey
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.66%
0.07%
자본화:
|
볼륨(24시간):